Patriot Financial Group Insurance Agency, LLC Incyte Corp Transaction History

Patriot Financial Group Insurance Agency, LLC

  • $704 Million
  • Q4 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 15, 2021
SELL
$80.74 - $97.7 $565 - $683
-7 Closed
0 $0
Q3 2020

Oct 21, 2020
BUY
$85.07 - $109.69 $425 - $548
5 Added 250.0%
7 $1,000
Q2 2020

Jul 10, 2020
BUY
$74.18 - $108.93 $148 - $217
2 New
2 $0
Q1 2020

Apr 15, 2020
SELL
$63.18 - $85.97 $31,590 - $42,985
-500 Closed
0 $0
Q4 2019

Jan 22, 2020
BUY
$73.04 - $95.72 $36,520 - $47,860
500 New
500 $44,000
Q2 2018

Aug 14, 2018
SELL
$60.85 - $83.98 $6,085 - $8,398
-100 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$83.06 - $100.98 $8,306 - $10,098
100 New
100 $8,000

Others Institutions Holding INCY

# of Institutions
666
Shares Held
187M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Patriot Financial Group Insurance Agency, LLC Portfolio

Follow Patriot Financial Group Insurance Agency, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email